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The impact of basal core promoter (BCP) and precore (PC) mutants of the hepatitis B
virus (HBV) on liver disease severity remains controversial. The aim of the present
study was to screen BCP and PC mutations in 252 HBV surface antigen (HBsAg)
positive carriers in France and to assess relationships between these mutations and
severe fibrosis.
Methods
Direct sequencing of the precore/core gene was used to detect A1762T/G1764A and
G1757A mutations in the BCP and G1896A and G1899A mutations in the PC region.
Results
The prevalences of A1762T/G1764A, G1757A, G1896A, and G1899A mutations were
34.1%, 38.7%, 54.9%, and 29.3% (P < 0.001), respectively. The independent
predictors of severe fibrosis (≥F3 Metavir) were older age (P < 0.001), male gender
(P = 0.012), elevated alanine aminotransferase (P < 0.001), and the double
A1762T/G1764A mutant with no other mutations (P = 0.011). Interestingly, the
association of the G1899A mutation with the double A1762T/G1764A mutant
significantly counteracted the deleterious effect of the sole double A1762T/G1764A
mutant (odds ratio [OR] = 0.28 vs. OR = 3.55, respectively, P = 0.028).
Conclusions
Patients with the A1762T/G1764A mutation have a higher risk of severe fibrosis. The
G1899A mutation is a protective factor against severe fibrosis that counteracted the
deleterious effect of the A1762T/G1764A mutation. Finally, host phenotypic and HBV
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